- Home
- GALT vs VATE Comparison
GALT vs VATE Comparison
Compare GALT & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | VATE |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | United States | United States |
| Employees | 9 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 228.1M |
| IPO Year | 2008 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GALT | VATE |
|---|---|---|
| Price | $4.63 | $14.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 114.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,246,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 12.55 |
| 52 Week Low | $2.03 | $3.75 |
| 52 Week High | $7.13 | $21.30 |
Technical Indicators
Market Signals| Indicator | GALT | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 72.46 | 41.57 |
| Support Level | $2.75 | $4.47 |
| Resistance Level | $5.21 | $20.45 |
| Average True Range (ATR) | 0.47 | 2.18 |
| MACD | 0.14 | -0.62 |
| Stochastic Oscillator | 80.23 | 13.33 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.